ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SUSAN MELTZER M.D.

At A Glance: This Prescriber in 2013

9,133Medicare Part D Prescriptions Filled, Including Refills
$654K Total Retail Price of All Prescriptions
440 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category
LISINOPRIL 325 307 81
LEVOTHYROXINE SODIUM 280 252 65
FUROSEMIDE 262 239 53
AMLODIPINE BESYLATE 259 254* 69
SIMVASTATIN 208 194 57
METOPROLOL TARTRATE 183 172 36
LOSARTAN POTASSIUM 175 164 46
OMEPRAZOLE 164 142 38
HYDROCHLOROTHIAZIDE 162 141 54
MIRTAZAPINE 161 161 30
HYDROCODONE-ACETAMINOPHEN 155 150* 37 S3
NAMENDA 148 148 19
SERTRALINE HCL 147 133 32
PRAVASTATIN SODIUM 142 128 45
ATORVASTATIN CALCIUM 142 137* 46
DONEPEZIL HCL 132 132 23
CLOPIDOGREL 126 126 20
PANTOPRAZOLE SODIUM 120 115* 31
JANTOVEN 118 118 11
POTASSIUM CHLORIDE 105 105 19
TRAMADOL HCL 102 97* 30
METOPROLOL SUCCINATE 99 99 27
CRESTOR 98 93* 27
ATENOLOL 97 92* 26
TAMSULOSIN HCL 97 97 17
ADVAIR DISKUS 88 73 27
GABAPENTIN 85 80* 26
CYMBALTA 77 54 18
METHYLPHENIDATE HCL 75 62 15 S2
VENLAFAXINE HCL ER 75 <11 <11
TRAZODONE HCL 72 67* 20
OXYCODONE HCL 72 47 16 S2
ZOLPIDEM TARTRATE 71 66* 17
METFORMIN HCL 68 63* 20
FLUTICASONE PROPIONATE 67 62* 24
DIGOX 67 67 11
LORAZEPAM 66 61* 23 B
ESCITALOPRAM OXALATE 66 54 19
LOVASTATIN 63 63 11
WARFARIN SODIUM 62 57* 15
PREDNISONE 61 56* 23
LABETALOL HCL 61 61 12
SYNTHROID 60 60 20
ALPRAZOLAM 53 48* 24 B
OXYBUTYNIN CHLORIDE ER 51 37 13
AZITHROMYCIN 50 45* 37
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.